Skip to main content

Peer Review reports

From: Acceptability, feasibility, and likelihood of stakeholders implementing the novel BPaL regimen to treat extensively drug-resistant tuberculosis patients

Original Submission
26 Oct 2020 Submitted Original manuscript
24 Dec 2020 Reviewed Reviewer Report
26 Dec 2020 Reviewed Reviewer Report
25 Jan 2021 Author responded Author comments - Sarah Elisabeth Josephine van de Berg
Resubmission - Version 2
25 Jan 2021 Submitted Manuscript version 2
14 Feb 2021 Reviewed Reviewer Report
27 Feb 2021 Reviewed Reviewer Report
16 Mar 2021 Author responded Author comments - Sarah Elisabeth Josephine van de Berg
Resubmission - Version 3
16 Mar 2021 Submitted Manuscript version 3
25 Mar 2021 Reviewed Reviewer Report
10 Apr 2021 Reviewed Reviewer Report
2 Jun 2021 Reviewed Reviewer Report
4 Jun 2021 Reviewed Reviewer Report - Roland Diel
15 Jun 2021 Author responded Author comments - Sarah Elisabeth Josephine van de Berg
Resubmission - Version 4
15 Jun 2021 Submitted Manuscript version 4
28 Jun 2021 Author responded Author comments - Sarah Elisabeth Josephine van de Berg
Resubmission - Version 5
28 Jun 2021 Submitted Manuscript version 5
Publishing
30 Jun 2021 Editorially accepted
16 Jul 2021 Article published 10.1186/s12889-021-11427-y

You can find further information about peer review here.

Back to article page